Category: Announcements

Medicines in Practice is a series of evidence–based publications specifically designed to support stakeholder medicines optimisation services.

This publication aims to provide guidance on what NHS prescribers need to be aware of when they are asked by a private healthcare provider, and/or patient, to take on the regular prescribing of a medication for a patient, including medicines supplied under formal shared care agreements. Based on suggested best practice it discusses the principles which underpin the transfer of patients from private to NHS provision and highlights Shared Care specific, and ethical considerations.

Medicines in Practice is a series of evidence–based publications specifically designed to support stakeholder medicines optimisation services.

Inhalers account for approximately 3% of all NHS carbon emissions. Reducing the carbon impact from inhaler prescribing has been identified as a significant area of focus for delivering a net zero NHS. This document aims to outline strategies that can be considered to promote optimal respiratory care, while minimising the environmental impact from inhalers and consequences of suboptimal disease management.

Prescribing for Population Health (PPH) is an ongoing series that aims to support ICSs to improve the health of the populations they serve.

Problematic polypharmacy is a significant concern with overprescribing and occurs where the prescribing of multiple medicines is either inappropriate or where the intended benefit of the medication is not realised.

The publication aims to raise awareness of potential prescribing cascades and to highlight resources, tools, and strategies to help identify, prevent, and resolve inappropriate cascades.

The RDTC has published a new Strategic Insights report on Electronic Repeat Dispensing: understanding the prescribing population & initial barriers to uptake.

Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System (ICS) leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees.

This report highlights the benefits of electronic repeat dispensing (eRD) and examines its use at ICS level in the North of England, in order to support systems in identifying where prescribing processes may be further streamlined.

Additional funding from NHS England regional teams has enabled this publication to be made available to non-stakeholders across the North East and Yorkshire, and North West. Further titles in this series will follow, see our work plan for more details.

If you have any queries or comments about this publication, please do not hesitate to contact us at nuth.nyrdtc.rxsupp@nhs.net.